Biological markers increase clinical trial success rate of new breast cancer drugs
Monday, October 1, 2012 - 12:30
in Health & Medicine
Using biological markers -- genetic characteristics that are associated with some patients with breast cancer -- can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research.